When we compared IL-10 levels only among drug-resistant patients in each epilepsy types, IL-10 levels were still significantly lower in the TLE + HS group than in the TLE-HS group (p = 0.013, Fig. 1) and IGE group (p = 0.039). This evidence concerns the gene IL10 and histiocytic sarcoma.